Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific region of the rat striatum after electroconvulsive stimuli.

[1]  C. Maggi,et al.  The mammalian tachykinin receptors. , 1995, General pharmacology.

[2]  N. Lindefors,et al.  Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. , 1995, Brain research. Molecular brain research.

[3]  N. Lindefors,et al.  Expression of mRNAs encoding dopamine receptors in striatal regions is differentially regulated by midbrain and hippocampal neurons. , 1994, Brain research. Molecular brain research.

[4]  E. Theodorsson,et al.  Repeated electroconvulsive stimuli: changes in neuropeptide Y, neurotensin and tachykinin concentrations in time , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  N. Lindefors,et al.  Differential Regulation of Preprotachykinin‐A mRNA Expression in Striatum by Excitation of Hippocampal Neurons , 1993, The European journal of neuroscience.

[6]  E. Theodorsson,et al.  Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin , 1992, Brain Research.

[7]  U. Ungerstedt,et al.  Amphetamine regulation of acetylcholine and γ-aminobutyric acid in nucleus accumbens , 1992, Neuroscience.

[8]  C. Gerfen.  D1 and D2 dopamine receptor regulation of striatonigral and striatopallidal neurons , 1992 .

[9]  N. Lindefors.  Amphetamine and haloperidol modulate preprotachykinin A mRNA expression in rat nucleus accumbens and caudate-putamen. , 1992, Brain research. Molecular brain research.

[10]  J. Cadet,et al.  Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat , 1990, Neuroscience Letters.

[11]  S. Nakanishi,et al.  Molecular characterization of a functional cDNA for rat substance P receptor. , 1989, The Journal of biological chemistry.

[12]  A. Wallin,et al.  A double‐blind evaluation of electroconvulsive therapy in Parkinson's disease with “on‐off” phenomena , 1987, Acta neurologica Scandinavica.

[13]  J. Chirgwin,et al.  Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Ljungberg,et al.  A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis , 1987, Brain Research.

[15]  T. Bonner,et al.  Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Kilts,et al.  Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens , 1986, Brain Research.

[17]  T. Bonner,et al.  Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. , 1986, The Journal of biological chemistry.

[18]  J. Gillin,et al.  Repeated electroconvulsive shocks and the brain content of endorphins , 1979, Brain Research.

[19]  D. Nutt,et al.  Psychopharmacology of Repeated Seizures: Possible Relevance to the Mechanism of Action of Electroconvulsive Therapy , 1987 .

[20]  S. Nakanishi,et al.  Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing , 1984, Nature.